Quadriceps muscle strength Handheld or fixed dynamometry · adults with advanced disease for muscle weakness
1 finding from 1 review
Safety Any serious adverse event · adults with advanced disease for muscle weakness
1 finding from 1 review
Safety Adverse events: Muscle discomfort · adults with advanced disease for muscle weakness
1 finding from 1 review
Muscle mass Anthropometry, DEXA, ultrasound, computed tomography · adults with advanced disease for muscle weakness
1 finding from 1 review
Exercise performance ‐ walking distance 6MWT, ISWT, ESWT · adults with advanced disease for muscle weakness
1 finding from 1 review
Change in peak oxygen uptake Cardiopulmonary exercise test · adults with advanced disease for muscle weakness
1 finding from 1 review
Deep vein thrombosis · participants at risk of venous thromboembolism
NMES showed no clear difference in total DVT compared with alternative prophylaxis (low certainty).
1 finding from 1 review
PE · participants at risk of venous thromboembolism
NMES showed no clear difference in PE compared with no prophylaxis (low certainty).
1 finding from 1 review
Total VTE · participants at risk of venous thromboembolism
NMES may leads to lower total VTE compared with no prophylaxis (low certainty).
1 finding from 1 review
Bleeding (major and minor) · participants at risk of venous thromboembolism
1 finding from 1 review
Deep vein thrombosis · participants at risk of venous thromboembolism
NMES may leads to higher total DVT compared with low‐dose heparin (low certainty).
1 finding from 1 review
Asymptomatic DVT · participants at risk of venous thromboembolism
NMES showed no clear difference in asymptomatic DVT compared with low‐dose heparin (low certainty).
1 finding from 1 review
Symptomatic DVT · participants at risk of venous thromboembolism
NMES showed no clear difference in symptomatic DVT compared with low‐dose heparin (low certainty).
1 finding from 1 review
PE · participants at risk of venous thromboembolism
1 finding from 1 review
Total VTE · participants at risk of venous thromboembolism
1 finding from 1 review
Bleeding (major and minor) · participants at risk of venous thromboembolism
1 finding from 1 review
Deep vein thrombosis · participants at risk of venous thromboembolism
NMES showed no clear difference in total DVT compared with dextran 40 (low certainty).
1 finding from 1 review
Asymptomatic DVT · participants at risk of venous thromboembolism
NMES showed no clear difference in asymptomatic DVT compared with alternative prophylaxis (low certainty).
1 finding from 1 review
Asymptomatic DVT · participants at risk of venous thromboembolism
1 finding from 1 review
Symptomatic DVT · participants at risk of venous thromboembolism
1 finding from 1 review